Login / Signup

Atrase B, a novel metalloprotease with anti-complement and anti-coagulant activity, significantly delays discordant cardiac xenograft rejection.

Cheng FuLei ShiXia HuangHao FengXiaosheng TanSong ChenLan ZhuQianyun SunGang Chen
Published in: Xenotransplantation (2020)
The dual activities of anti-complement and anti-coagulation make atrase B a potential adjuvant therapeutic drug for use in xenotransplantation.
Keyphrases
  • early stage
  • emergency department
  • heart failure
  • risk assessment